Intellectual Proprety Archives - Page 4 of 4

10 July 2014

The first Middle East and North Africa Community Advisory Board (MENA-CAB)

Advocacy, AIDS, Algeria, ARV, Daclatasvir, Dolutegravir, Guidelines, HIV, Intellectual Proprety, Libya, Middle East, Morocco, North Africa, REGION, Tunisia 51 Views

Casablanca, Morocco, 28 June-01 July 2014 Despite the fact that HIV prevalence in the countries of the Middle East and North Africa is believed to be low at least among the General Population,Read More

28 February 2014

Pharma Refuses to Ensure Access to Lifesaving Hepatitis C Treatment at Global Meeting

Advocacy, ARV, HCV, Health Financing, Hepatitis, Intellectual Proprety, Medias 49 Views

Bangkok, Thailand, February 28, 2014 —Thirty-eight activists from 22 countries joined forces at the first-ever Hepatitis C Virus (HCV) World Community Advisory Board (CAB) to demand equitable access to treatment for hepatitis CRead More